SCHEMBL18448722

SCHEMBL18448722

CC(Nc1cnccn1)c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR2 O15552 1/20 0.57
KDM4E B2RXH2 3/20 0.50
JAK2 O60674 2/20 0.50
JAK3 P52333 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 2/20 0.49
HPGD P15428 1/20 0.48
HSD17B10 Q99714 1/20 0.48
ATP1A1 P05023 1/20 0.47
ATP1B1 P05026 1/20 0.47
ATP1A3 P13637 1/20 0.47
ATP1B2 P14415 1/20 0.47
ATP1A2 P50993 1/20 0.47
ATP1B3 P54709 1/20 0.47
FXYD2 P54710 1/20 0.47
ATP1A4 Q13733 1/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
CAMK2D Q13557 1/20 0.44
JAK1 P23458 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17560899 0.84 ATP1A1 (0.49) FFAR2JAK2JAK3KMT2AHPGD
SCHEMBL4312347 0.83 MAPKAPK2 (0.56) KDM4EJAK2JAK3ALDH1A1KMT2A
SCHEMBL2054165 0.83 MAPKAPK2 (0.56) KDM4EJAK2JAK3ALDH1A1KMT2A
SCHEMBL23780413 0.80 ALDH1A1 (0.54) KDM4EJAK2JAK3ALDH1A1HPGD
SCHEMBL23291896 0.80 ALDH1A1 (0.54) KDM4EJAK2JAK3ALDH1A1HPGD
SCHEMBL23291971 0.77 HDAC3 (0.41) FFAR2KDM4EJAK2JAK3ALDH1A1
SCHEMBL23780410 0.77 HDAC3 (0.41) FFAR2KDM4EJAK2JAK3ALDH1A1
SCHEMBL1367151 0.77 JAK2 (0.68) JAK2JAK3JAK1TYK2GPR55
SCHEMBL14954526 0.77 JAK2 (0.57) FFAR2JAK2JAK3JAK1TYK2
SCHEMBL30765607 0.75 GPR55 (0.51) JAK2JAK3KMT2AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331863-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2018-06-13 EP disclosed
WO-2017021879-A1 NOVEL COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2017-02-09 WO disclosed